Blocking plasma cell fate enhances antigen-specific presentation by B cells to boost anti-tumor immunity
Abstract B cells engage in anti-tumor immunity but how they contribute to cancer suppression remains unclear. We report that inhibiting plasma cell differentiation either in IgMi mice lacking Igh elements needed for antibody secretion or in mice with B cell-specific knockout of Blimp-1 (Blimp-1 BcKO...
Saved in:
| Main Authors: | Yunqiao Li, Raag Bhargava, Jenny Tuyet Tran, Tanya R. Blane, Linghang Peng, Fangkun Luan, Zhe Huang, Zefan Zhang, Yunfan Sun, Changchun Xiao, David Nemazee |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2025-05-01
|
| Series: | Nature Communications |
| Online Access: | https://doi.org/10.1038/s41467-025-59622-4 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Afatinib boosts CAR-T cell antitumor therapeutic efficacy via metabolism and fate reprogramming
by: Xi Zhang, et al.
Published: (2024-11-01) -
Enzyme-activating B-cell receptors boost antigen presentation to pathogenic T cells in gluten-sensitive autoimmunity
by: Rasmus Iversen, et al.
Published: (2025-03-01) -
Splicing to orchestrate cell fate
by: Xurui Zhang, et al.
Published: (2025-03-01) -
Machine-guided cell-fate engineering
by: Evan Appleton, et al.
Published: (2025-06-01) -
Landscape control for cell fate transitions
by: Jinchao Lv, et al.
Published: (2025-06-01)